Isleworth Healthcare Acquisition Corp.

NasdaqCM:ISLE Stock Report

Market Cap: US$262.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Isleworth Healthcare Acquisition Management

Management criteria checks 0/4

Key information

Bob Whitehead

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.4yrs

Recent management updates

No updates

Recent updates

Isleworth Healthcare Acquisition, Cytovia terminate merger pact

Jul 01

CEO

Bob Whitehead (71 yo)

no data

Tenure

Mr. Robert S. Whitehead, also known as Bob, serves as the Chief Executive Officer and Director at Isleworth Healthcare Acquisition Corp. Mr. Whitehead co-founded Sprout Pharmaceuticals, Inc. in 2011 and ha...


Board Members

NamePositionTenureCompensationOwnership
Robert Whitehead
CEO & Directorno datano datano data
Danny Halvorson
CFO, Executive VP & Directorno datano datano data
W. Dahl
Independent Director1.4yrsno data0.14%
$ 360.4k
Allen Weiss
Independent Chairmanno datano datano data
Vipul Patel
Independent Director1.4yrsno datano data
Michelle McKenna-Doyle
Independent Director1.4yrsno data0.14%
$ 360.4k
Monica Reed
Independent Directorless than a yearno data0.14%
$ 360.4k

1.4yrs

Average Tenure

58yo

Average Age

Experienced Board: ISLE's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.